Pyxis Oncology is a preclinical stage biopharmaceutical company that develops therapies to treat cancers. Its product candidates include immune-oncology therapies and antibody drug conjugates for the treatment of a range of solid tumors. The company was founded in 2018 and is based in Cambridge, Massachusetts.